Disclaimer: All information on this section is of a general nature.
Before making any investment decision, you should consult your adviser.

Investment Ideas - Integral Diagnostics (IDX)

Off the back of a disappointing FY16 which proved to be a tough market for the Australian diagnostic imaging industry, we believe that IDX looks set to improve as short term headwinds pass.

The IRESS consensus target price of $1.53 indicates some 24% upside potential relative to IDX’s current share price of $1.23. When added to an IRESS consensus dividend yield of ~6%, we calculate that IDX offers total potential upside of around 30%.
23/01/2017 12:23:41 PM

Back to top